Weaning of non COPD patients at high-risk of extubation failure assessed by lung ultrasound: the WIN IN WEAN multicentre randomised controlled trial

期刊论文
出版模式：

开放获取
发表日期：

2024年11月26日

查看全文

Jean-Jacques Rouby,
Sébastien Perbet,
Jean-Pierre Quenot,
Mao Zhang,
Pascal Andreu,
Mona Assefi,
Yuzhi Gao,
Romain Deransy,
Jie Lyu,
Charlotte Arbelot,
Youzhong An,
Antoine Monsel,
Xia Jing,
Philippe Guerci,
Chuanyun Qian,
Luiz Malbouisson,
Dominique Morand,
Louis Puybasset,
Emmanuel Futier,
Jean-Michel Constantin,
Bruno Pereira,
Nicolas Adam,
Marine Lecorre,
Hélène Brisson,
Matthieu Jabaudon,
Russel Chabanne,
Sylvia Collomb,
Marie Labruyère,
Jean-Baptiste Roudaut,
Marine Jacquier,
Shan Lyu,
Yang Ting,
Julien Birckener,
Laura Chenard,
Benoît Longère,
Pierre-Eric Danin,
Jean-François Payen,
Florent Wallet,
Felippe Dexheimer

摘要

Background

Postextubation respiratory failure (PRF) frequently complicates weaning from mechanical ventilation and may increase morbidity/mortality. Noninvasive ventilation (NIV) alternating with high-flow nasal oxygen (HFNO) may prevent PRF.

Methods

Ventilated patients without chronic obstructive pulmonary disease (COPD) and at high-risk of PRF defined as a lung ultrasound score (LUS) ≥ 14 assessed during the spontaneous breathing trial, were included in a French-Chinese randomised controlled trial. PRF was defined by 2 among the following signs: SpO₂ < 90%; Respiratory rate > 30 /min; hypercapnia; haemodynamic and/or neurological disturbances of respiratory origin. In the intervention group, prophylactic NIV alternating with HFNO was administered for 48 h following extubation. In the control group, conventional oxygen was used. Clinicians were informed on the LUS in the intervention group, those in the control group remained blind. The primary outcome was the incidence of PRF 48 h after extubation. Secondary outcomes were incidence of PRF and reintubation at day 7, number of ventilator-free days at day 28, length of ICU stay and mortality at day 28 and 90.

Results

Two hundred and forty patients were randomised and 227 analysed (intervention group = 128 and control group = 99). PRF at H48 was reduced in the intervention group compared to the control group: relative risk 0.52 (0.31 to 0.88), p = 0.01. The benefit persisted at day 7: relative risk 0.62 (0.44 to 0.96), p = 0.02. Weaning failure imposing reconnection to mechanical ventilation was not reduced. In patients who developed PRF and were treated by rescue NIV, reintubation was avoided in 44% of control patients and in 12% of intervention patients (p = 0.008). Other secondary outcomes were not different between groups. From a resource utilisation standpoint, prophylactic NIV alternating with HFNO was more demanding and costly than conventional oxygen with rescue NIV to achieve same clinical outcome.

Conclusions

Compared to conventional oxygenation, prophylactic NIV alternating with HFNO significantly reduced postextubation respiratory failure but failed to reduce reintubation rate and mortality in patients without COPD at high risk of extubation failure. Prophylactic NIV alternating with HFNO was as efficient as recue NIV to treat postextubation respiratory failure.